Notice: Trading of Traws Pharma halted at 09:31 AM EST due to "LULD pause". Traws Pharma (TRAW) Short Interest Ratio & Short Volume $4.48 -0.01 (-0.22%) (As of 02:15 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends Traws Pharma Short Interest DataTraws Pharma (TRAW) has a short interest of 7,400 shares, representing 0.25% of the float (the number of shares available for trading by the public). This marks a -23.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 5,880 shares to cover all short positions.Current Short Interest7,400 sharesPrevious Short Interest9,700 sharesChange Vs. Previous Month-23.71%Dollar Volume Sold Short$37,296.00Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,830,000 sharesFloat Size3,000,000 sharesShort Percent of Float0.25%Today's Trading Volume3,162 sharesAverage Trading Volume5,880 sharesToday's Volume Vs. Average54% Short Selling Traws Pharma? Sign up to receive the latest short interest report for Traws Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRAW Short Interest Over TimeTRAW Days to Cover Over TimeTRAW Percentage of Float Shorted Over Time Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Traws Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20247,400 shares $37,296.00 -23.7%0.3%0.7 $5.04 10/15/20249,700 shares $46,560.00 -24.2%0.3%1.1 $4.80 9/30/202412,800 shares $75,264.00 +652.9%0.6%1.6 $5.88 9/15/20241,700 shares $594.49 -92.7%N/A0.3 $0.35 8/31/202423,400 shares $8,669.70 +2.6%0.1%0.3 $0.37 8/15/202422,800 shares $8,208.00 +40.7%0.1%0.2 $0.36 7/31/202416,200 shares $6,416.82 -60.7%0.1%0.2 $0.40 7/15/202441,200 shares $17,711.88 No Change0.2%0.4 $0.43 TRAW Short Interest - Frequently Asked Questions What is Traws Pharma's current short interest? Short interest is the volume of Traws Pharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 7,400 shares of TRAW short. 0.25% of Traws Pharma's shares are currently sold short. Learn More on Traws Pharma's current short interest. What is a good short interest ratio for Traws Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRAW shares currently have a short interest ratio of 1.0. Learn More on Traws Pharma's short interest ratio. What is a good short interest percentage for Traws Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of Traws Pharma's floating shares are currently sold short. Is Traws Pharma's short interest increasing or decreasing? Traws Pharma saw a drop in short interest in October. As of October 31st, there was short interest totaling 7,400 shares, a drop of 23.7% from the previous total of 9,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Traws Pharma's float size? Traws Pharma currently has issued a total of 1,830,000 shares. Some of Traws Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Traws Pharma currently has a public float of 3,000,000 shares. How does Traws Pharma's short interest compare to its competitors? 0.25% of Traws Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Traws Pharma: Lexaria Bioscience Corp. (1.72%), Hookipa Pharma Inc (0.47%), Lantern Pharma Inc. (2.06%), BioVie Inc. (35.04%), ProMIS Neurosciences, Inc. (1.16%), Janone Inc. (1.13%), Acasti Pharma Inc. (2.47%), DURECT Co. (3.35%), Ocuphire Pharma, Inc. (3.59%), KALA BIO, Inc. (1.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Traws Pharma stock? Short selling TRAW is an investing strategy that aims to generate trading profit from Traws Pharma as its price is falling. TRAW shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Traws Pharma? A short squeeze for Traws Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRAW, which in turn drives the price of the stock up even further. How often is Traws Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRAW, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies PMN Short Interest LTRN Short Interest ACST Short Interest CTXR Short Interest ALTS Short Interest OCUP Short Interest BIVI Short Interest KALA Short Interest HOOK Short Interest RNXT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRAW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.